Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Dumex history
Dumex company history timeline
1946 A/S Dumex is founded by The East Asiatic Company
1954 Production of the company's new core product, Bacitracin, begins in Oslo, Norway
1961 A/S Dumex in Denmark begins production of Tetracyclin
PT. Actavis Indonesia operations began on November 8, 1969, with the inauguration by the late President of the Republic of Indonesia at the time, Mr.
1983 A.L. Laboratories Inc. acquires A/S Dumex and the company becomes a subsidiary of A.L. Laboratories Inc
1985 Production of Amphotericin B begins in Copenhagen, Denmark
1991 The Bacitracin business of Lundbeck is acquired and the company becomes the world leading supplier of Bacitracin for human and veterinary use
1997 Alpharma acquires certain technologies from Cultour Food Science, Inc
2003 A new state-of-the-art bulk, robotized, freeze drying department for Vancomycin is opened in Copenhagen, Denmark
2007 The company acquires a distribution and trading company in Japan, Nippon Dumex.
2014 Xellia acquires manufacturing facilities in Raleigh, North Carolina, USA
2017 Xellia expands its Budapest facilities with the build of a new 3,000m2 Centralized Laboratory Services building.
2019 Divests Raleigh, North Carolina production facilities to Sagent Pharmaceuticals
2021 Xellia joins Medicines for Europe to support better access to critical medicines
© Xellia Pharmaceuticals 2022
Rate Dumex's efforts to communicate its history to employees.
Dumex jobs
Do you work at Dumex?
Is Dumex's vision a big part of strategic planning?
Dumex history FAQs
Zippia gives an in-depth look into the details of Dumex, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Dumex. The employee data is based on information from people who have self-reported their past or current employments at Dumex. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Dumex. The data presented on this page does not represent the view of Dumex and its employees or that of Zippia.
Dumex may also be known as or be related to Dumex.